Our Research Groups

We are focused on exciting areas of research, learn more.

See All Research Groups

Latest News

With two RNAi-based therapies acquired from other companies already in the clinic, Pfizer is now aiming to have an entirely internally developed RNAi drug ready to enter human trials within three years, a senior company official told RNAi News
last week.
 

Read This Publication

See All Articles